Leica Biosystems Bond Oracle HER2 IHC System User Manual

Page 13

Advertising
background image

Page 13 of 23

English

Leica Biosystems Bond Oracle HER2 IHC System Instructions for Use TA9145 EN-CE-Rev_E 18/06/2013

English

Nonspecific staining, if present, usually has a diffuse appearance. Sporadic staining of

connective tissue may also be observed in sections from excessively formalin-fixed tissues.

Use intact cells for interpretation of staining results. Necrotic or degenerated cells often stain

nonspecifically (16). False-positive results may be seen due to non-immunological binding of

proteins or substrate reaction products. They may also be caused by endogenous enzymes

such as pseudoperoxidase (erythrocytes) or endogenous peroxidase (cytochrome C),

depending on the type of immunohistochemical stain used.
Tissues from patients infected with Hepatitis B virus and containing Hepatitis B virus surface

antigen (HBsAg) may exhibit nonspecific staining with horseradish peroxidase (17).
Unexpected immunohistochemical staining, or variations in the staining, may be as a result

of alterations in the expression levels of the encoding genes or antigens. Any change in

expected staining patterns should be interpreted in association with all other diagnostic

investigations.
The interpretation of immunohistochemical staining should be complemented by morphological

studies and the use of suitable control material, and should be evaluated within the context of

the patient’s clinical history and other any diagnostic tests by a qualified pathologist.
The performance of the assay (ie assessments of adequacy of both positive and negative

controls) and the interpretation of any immunohistochemical staining or its absence must

be carried out in an appropriately accredited/licensed laboratory under the supervision of a

suitably qualified and experienced pathologist, who is responsible for the overall assessment

of the immunohistochemical assay and its interpretation.

B. Product Specific Limitations

This product is not intended for use in flow cytometry. Performance characteristics have not

been determined for flow cytometry.
False negative results may be seen as a result of the degradation of antigens in the tissue

section. Slides required for HER2 oncoprotein evaluation and tumor verification should be

prepared at the same time. To preserve antigenicity, tissue sections mounted on slides

(Leica BOND Plus Slides – product code S21.2113) should be stained within 4–6 weeks

of sectioning when held at room temperature (20–25 °C). Following sectioning, slides are

recommended to be incubated for 12–18 hours at 37 °C. Sections which require further

adherence may be incubated at 60 °C for a further hour.
Minimal natural variation of immunohistochemical profile will be seen between growth batches

of cell lines utilized within the Bond Oracle HER2 IHC System. This natural variation is well

within acceptable tolerance levels of a biological entity and does not affect the interpretation

or performance of the system.
Characterization of the cell lines using both flow cytometry and in situ hybridization

as presented in Table 5 are also subject to natural biological variation. Technical and

interpretational variation of control cell lines as assessed by fluorescent in situ hybridization

is also reported (18).
Assessment of the HER2 Control Slides should take into account all relevant expiry dates.

Store the Bond Oracle HER2 IHC System at 2–8 °C. Do not freeze. Return to 2–8 °C

immediately after use. Any deviations from these conditions will invalidate the assay.
Do not replace Bond Oracle HER2 IHC System reagents with any other components either

supplied by Leica Biosystems or by other manufacturers. To do so will invalidate the assay.
It is essential that all of the steps outlined in sections C to E (Procedure) are performed in the

prescribed order. Any deviation from this order will invalidate the assay.
It is essential that tissues fixed only in formalin-based fixatives be used in the assay. The use

of any other type of fixative will invalidate the assay.
Tissue sections cut outside of the recommended thickness range have not been validated.

The use of any other section thickness may invalidate the assay.

Advertising